Macleods Pharma USA, Inc.

Macleods Pharma USA, Inc. is the U.S. subsidiary of Macleods Pharmaceuticals Ltd., an India-headquartered generic drugmaker founded in 1989 and based in Mumbai (Andheri East). The U.S. entity was registered in 2012 and is headquartered in New Jersey (Plainsboro, later Princeton). The parent is a closely held, unlisted public limited company; its U.S. arm is not separately traded. Parent revenue was about ₹9,672 crore (~US$1.1B) for FY2025, per Indian MCA filings. Court filings describe the parent as having 10,000+ employees globally; business-data aggregators list roughly 20,000+ across the group. Third-party sources give the U.S. subsidiary at 100–200 employees and $10–50M revenue, but those figures are estimates and not independently verified.

Operations. Macleods develops, manufactures and markets generic finished dosage forms — solid orals, injectables, inhalers/DPIs, topicals and APIs — across anti-infectives, anti-tuberculosis and antiretroviral, cardiovascular, anti-diabetic, dermatology and hormone therapies. The U.S. subsidiary functions as the regulatory and commercial arm: it imports finished generics manufactured at parent plants (e.g., Baddi) and distributes them in the U.S. Customs records show key U.S. products including hydrochlorothiazide, valsartan, irbesartan, pioglitazone and montelukast.

Litigation posture. Macleods is an operating company, not an NPE. Tracked data shows 1 case, all as defendant and zero as plaintiff — the classic profile of a generic manufacturer defending brand-owner patent suits rather than asserting patents. The single appearance is in the District of Delaware, not a plaintiff-friendly NPE venue.

Notable case. Merck Sharp & Dohme Corp. v. Macleods Pharmaceuticals Ltd. et al., filed 2019-02-13 in D. Del., a Hatch-Waxman/ANDA action naming the U.S. and Indian entities. Delaware is the standard venue for such ANDA disputes given that many brand holders are incorporated there; public dockets also reflect subsequent ANDA litigation against the company, though those are outside the tracked set.